Literature DB >> 26163214

TNF-Binding domain of the variola virus CrmB protein synthesized in Escherichia coli cells effectively interacts with human TNF.

T V Tregubchak1, S V Shekhovtsov, T S Nepomnyashchikh, S E Peltek, N A Kolchanov, S N Shchelkunov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26163214     DOI： 10.1134/S1607672915030102

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.834


× No keyword cloud information.
  11 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population.

Authors:  Vernon F Schabert; Crystal Watson; George J Joseph; Paige Iversen; Chakkarin Burudpakdee; David J Harrison
Journal:  J Manag Care Pharm       Date:  2013-10

3.  [Modeling spatial structures of variola and cowpox virus TNF-binding CrmB proteins bound to murine or human TNF].

Authors:  T S Nepomniashchikh; D V Antonets; L R Lebedev; I P Gileva; S N Shchelkunov
Journal:  Mol Biol (Mosk)       Date:  2010 Nov-Dec

4.  Properties of the recombinant TNF-binding proteins from variola, monkeypox, and cowpox viruses are different.

Authors:  Irina P Gileva; Tatiana S Nepomnyashchikh; Denis V Antonets; Leonid R Lebedev; Galina V Kochneva; Antonina V Grazhdantseva; Sergei N Shchelkunov
Journal:  Biochim Biophys Acta       Date:  2006-09-19

5.  Recombinant TNF-binding protein from variola virus as a novel potential TNF antagonist.

Authors:  I P Gileva; T S Nepomnyashchikh; I A Ryazankin; S N Shchelkunov
Journal:  Biochemistry (Mosc)       Date:  2009-12       Impact factor: 2.487

6.  SECRET domain of variola virus CrmB protein can be a member of poxviral type II chemokine-binding proteins family.

Authors:  Denis V Antonets; Tatyana S Nepomnyashchikh; Sergei N Shchelkunov
Journal:  BMC Res Notes       Date:  2010-10-27

Review 7.  Gene therapy for rheumatoid arthritis: recent advances.

Authors:  James M Woods; Yasmin Sitabkhan; Alisa E Koch
Journal:  Curr Gene Ther       Date:  2008-02       Impact factor: 4.391

Review 8.  Arthritis gene therapy and its tortuous path into the clinic.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Transl Res       Date:  2013-01-29       Impact factor: 7.012

9.  A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.

Authors:  Alí Alejo; M Begoña Ruiz-Argüello; Yin Ho; Vincent P Smith; Margarida Saraiva; Antonio Alcami
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 12.779

10.  The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients.

Authors:  Chamaida Plasencia; Dora Pascual-Salcedo; Sara García-Carazo; Leticia Lojo; Laura Nuño; Alejandro Villalba; Diana Peiteado; Florencia Arribas; Jesus Díez; Maria Teresa López-Casla; Emilio Martín-Mola; Alejandro Balsa
Journal:  Arthritis Res Ther       Date:  2013-07-26       Impact factor: 5.156
View more
  1 in total

1.  The gene therapy of collagen-induced arthritis in rats by intramuscular administration of the plasmid encoding TNF-binding domain of variola virus CrmB protein.

Authors:  S N Shchelkunov; O S Taranov; T V Tregubchak; R A Maksyutov; A N Silkov; A E Nesterov; S V Sennikov
Journal:  Dokl Biochem Biophys       Date:  2016-09-07       Impact factor: 0.788
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.